pamidronate has been researched along with Amyotonia Congenita in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "5) nonambulatory children with cerebral palsy or a neuromuscular disorder received cyclic intravenous administration of pamidronate." | 9.11 | Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. ( Allington, N; Gerard, P; Vivegnis, D, 2005) |
| "5) nonambulatory children with cerebral palsy or a neuromuscular disorder received cyclic intravenous administration of pamidronate." | 5.11 | Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. ( Allington, N; Gerard, P; Vivegnis, D, 2005) |
| "Osteoporosis is a common complication in children with motor impairments." | 1.37 | Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders. ( Berard, C; Poirot, I; Vuillerot, C; Wagner, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, S | 1 |
| Poirot, I | 1 |
| Vuillerot, C | 1 |
| Berard, C | 1 |
| Allington, N | 1 |
| Vivegnis, D | 1 |
| Gerard, P | 1 |
1 trial available for pamidronate and Amyotonia Congenita
| Article | Year |
|---|---|
Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
Topics: Adolescent; Anti-Inflammatory Agents; Cerebral Palsy; Child; Child, Preschool; Diphosphonates; Drug | 2005 |
1 other study available for pamidronate and Amyotonia Congenita
| Article | Year |
|---|---|
Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
Topics: Adolescent; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Drug Evaluation; Fe | 2011 |